4S: Scandinavian Simvastatin Survival Study

Scandinavian Simvastatin Survival Study Group • Lancet

Key Finding

Statin therapy significantly reduces mortality in CHD patients.

Original title: “Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).”

Plain English Summary

Landmark trial proving statin therapy reduces mortality in patients with coronary heart disease.

Paradigm Relevance

How this study applies to different clinical perspectives:

Standard Medical

Relevant

Conventional clinical guidelines used by most doctors

Research Consensus

Current scientific understanding, often ahead of guidelines

Not directly relevant to this paradigm

Metabolic Optimization

Proactive targets for optimal health, not just disease absence

Not directly relevant to this paradigm

Study Details

Type: Landmark Study

Related Biomarkers

LDL CHOLESTEROL

Original Source

View on PubMed